MPWT
ITOS

MassMutual Private Wealth & Trust’s iTeos Therapeutics ITOS Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-162
Closed -$2.15K – 2000
2023
Q2 		$2.15K Buy
162
+79
+95% +$1.13K ﹤0.01% 1452
2023
Q1 		$1.13K Buy
+83
New +$1.49K ﹤0.01% 1557

Other funds holding ITOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MassMutual Private Wealth & Trust's ITOS Position: Q3 2023 in Review

MassMutual Private Wealth & Trust sold out of iTeos Therapeutics (ITOS) in Q3 2023, closing a stake of 162 shares — an estimated $2.15K sold.

MassMutual Private Wealth & Trust first reported a position in ITOS in Q1 2023 and held it in 2 quarters. The position peaked at $2.15K in Q2 2023. 144 funds tracked by Wall St. Rank hold ITOS as of Q3 2023.

  • MassMutual Private Wealth & Trust reported no remaining iTeos Therapeutics position as of Q3 2023 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 162 iTeos Therapeutics shares in Q3 2023, an estimated $2.15K.
  • MassMutual Private Wealth & Trust first reported a position in iTeos Therapeutics in Q1 2023 and held it in 2 quarters.
  • MassMutual Private Wealth & Trust's iTeos Therapeutics position peaked at $2.15K in Q2 2023.
  • 144 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2023.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2023, filed 4 Oct 2023.